An Electronic Medication Module to Improve Health Literacy in Patients With Type 2 Diabetes Mellitus: Pilot Randomized Controlled Trial

被引:7
|
作者
Seidling, Hanna Marita [1 ,2 ]
Mahler, Cornelia [3 ,4 ]
Strauss, Beate [3 ]
Weis, Aline [3 ]
Stutzle, Marion [1 ,2 ]
Krisam, Johannes [5 ]
Infopat, P. [4 ]
Szecsenyi, Joachim [3 ]
Haefeli, Walter Emil [1 ]
机构
[1] Heidelberg Univ Hosp, Dept Clin Pharmacol & Pharmacoepidemiol, Neuenheimer Feld 410, D-69120 Heidelberg, Germany
[2] Heidelberg Univ Hosp, Cooperat Unit Clin Pharm, Heidelberg, Germany
[3] Heidelberg Univ Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany
[4] Univ Hosp Tuebingen, Dept Nursing Sci, Tubingen, Germany
[5] Heidelberg Univ Hosp, Inst Med Biometry & Informat, Heidelberg, Germany
关键词
medication self-management; patient empowerment; health literacy; chronic diseases; type 2 diabetes mellitus; electronic health record; PEPA; electronic medication module; structured medication review;
D O I
10.2196/13746
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: In primary care, patients play a crucial role in managing care processes and handling drug treatment. A decisive factor for success is their health literacy, and several interventions have been introduced to support patients in fulfilling their responsibility. Objective: The aim of this study is to assess the influence of such an intervention (ie, a medication module) within a patient-led electronic health record on patients' health literacy. Methods: We conducted a randomized controlled study among community-dwelling patients with type 2 diabetes mellitus. Patients were recruited from primary care practices. After randomization, patients either had access to an internet-based medication module allowing them to store their medication information, look up drug information, and print a medication schedule (intervention group), or they received an information brochure on the importance of medication schedules (control group). After 4-8 weeks, all patients were invited to attend a structured medication review (ie, follow-up visit). Data were collected via questionnaires before the start of the intervention and during the follow-up visit. The main outcome measure was the mean difference in health literacy between baseline and follow-up assessments of patients in the control and intervention groups. Results: Of 116 recruited patients, 107 (92.2%) completed the follow-up assessment and were eligible for intention-to-treat analyses. Only 73 patients, of which 29 were in the intervention group, followed the study protocol and were eligible for per-protocol analysis. No differences in overall health literacy were observed in either the intention-to-treat or in the per-protocol cohorts. Reasons for a null effect might be that the cohort was not particularly enriched with participants with low health literacy, thus precluding measurable improvement (ie, ceiling effect). Moreover, the success of implementation was considered poor because both the correct application of the study procedure (ie, randomization according to the protocol and dropout of 29 patients) and the actual interaction with the medication module was modest (ie, dropout of 9 patients). Conclusions: The conduct of this randomized controlled study was challenging, leaving it open whether inadequate implementation, too short of a duration, or insufficient efficacy of the intervention, as such, contributed to the null effect of this study. This clearly outlines the value of piloting complex interventions and the accompanying process evaluations.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Reduction of Microalbuminuria by using Losartan in Normotensive Patients with Type 2 Diabetes Mellitus: a Randomized Controlled Trial
    Agha, Adnan
    Amer, Wasim
    Anwar, Eram
    Bashir, Kaukab
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2009, 20 (03) : 429 - 435
  • [42] Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus - A randomized controlled trial
    Fonseca, V
    Rosenstock, J
    Patwardhan, R
    Salzman, A
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (13): : 1695 - 1702
  • [43] Inflammatory markers response to crocin supplementation in patients with type 2 diabetes mellitus: A randomized controlled trial
    Behrouz, Vahideh
    Sohrab, Golbon
    Hedayati, Mehdi
    Sedaghat, Meghdad
    PHYTOTHERAPY RESEARCH, 2021, 35 (07) : 4022 - 4031
  • [44] Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial
    Oh, Tae Jung
    Yu, Jae Myung
    Min, Kyung Wan
    Son, Hyun Shik
    Lee, Moon Kyu
    Yoon, Kun Ho
    Song, Young Duk
    Park, Joong Yeol
    Jeong, In Kyung
    Cha, Bong Soo
    Kim, Yong Seong
    Baik, Sei Hyun
    Kim, In Joo
    Kim, Doo Man
    Kim, Sung Rae
    Lee, Kwan Woo
    Park, Jeong Hyung
    Lee, In Kyu
    Park, Tae Sun
    Choi, Sung Hee
    Park, Sung Woo
    DIABETES & METABOLISM JOURNAL, 2019, 43 (03) : 276 - 286
  • [45] Efficacy of Spirulina (Tahlab) in Patients of Type 2 Diabetes Mellitus (Ziabetus Shakri) - A Randomized Controlled Trial
    Alam, Anzar
    Quamri, Siddiqui
    Fatima, Sana
    Roqaiya, Mariyam
    Ahmad, Zaheer
    JOURNAL OF DIABETES & METABOLISM, 2016, 7 (10)
  • [46] Physician step prescription and monitoring to improve ARTERial health (SMARTER): A randomized controlled trial in patients with type 2 diabetes and hypertension
    Dasgupta, Kaberi
    Rosenberg, Ellen
    Joseph, Lawrence
    Cooke, Alexandra B.
    Trudeau, Luc
    Bacon, Simon L.
    Chan, Deborah
    Sherman, Mark
    Rabasa-Lhoret, Remi
    Daskalopoulou, Stella S.
    DIABETES OBESITY & METABOLISM, 2017, 19 (05): : 695 - 704
  • [47] Analysis of Readiness for enhanced health literacy in patients with type 2 diabetes mellitus
    de Almeida, Jocelha Maria Costa
    Serra, Eliana Brugin
    Pascoal, Livia Maia
    Santos Neto, Marcelino
    Moreira, Rafaella Pessoa
    Rolim, Isaura Leticia Tavares Palmeira
    INTERNATIONAL JOURNAL OF NURSING KNOWLEDGE, 2024, 35 (01) : 75 - 82
  • [48] Efficacy of cinnamon in patients with type II diabetes mellitus: A randomized controlled clinical trial
    Zare, Roghayeh
    Nadjarzadeh, Azadeh
    Zarshenas, Mohammad Mehdi
    Shams, Mesbah
    Heydari, Mojtaba
    CLINICAL NUTRITION, 2019, 38 (02) : 549 - 556
  • [49] THE IMPACT OF PHARMACIST-LED MEDICATION THERAPY MANAGEMENT ON MEDICATION ADHERENCE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A RANDOMIZED CONTROLLED STUDY
    Erku, D. A.
    Belachew, S. A.
    Tegegn, H. G.
    Ayele, A. A.
    VALUE IN HEALTH, 2017, 20 (09) : A402 - A402
  • [50] Insulin degludec in Japanese patients with type 1 diabetes mellitus: A randomized controlled trial
    Iwamoto, Yasuhiko
    Clauson, Per
    Nishida, Tomoyuki
    Kaku, Kohei
    JOURNAL OF DIABETES INVESTIGATION, 2013, 4 (01) : 62 - 68